关注
Xiang Zhao
Xiang Zhao
在 sibcb.ac.cn 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticles
Y Zhong, Z Ma, F Wang, X Wang, Y Yang, Y Liu, X Zhao, J Li, H Du, ...
Nature biotechnology 37 (11), 1322-1331, 2019
4322019
Tuning T cell receptor sensitivity through catch bond engineering
X Zhao, EM Kolawole, W Chan, Y Feng, X Yang, MH Gee, KM Jude, ...
Science 376 (6589), eabl5282, 2022
662022
Autoimmunity-associated T cell receptors recognize HLA-B* 27-bound peptides
X Yang, LI Garner, IV Zvyagin, MA Paley, EA Komech, KM Jude, X Zhao, ...
Nature 612 (7941), 771-777, 2022
552022
Lck bound to coreceptor is less active than free Lck
Q Wei, J Brzostek, S Sankaran, J Casas, LSQ Hew, J Yap, X Zhao, ...
Proceedings of the National Academy of Sciences 117 (27), 15809-15817, 2020
462020
T cell receptor and cytokine signal integration in CD8+ T cells is mediated by the protein Themis
J Brzostek, N Gautam, X Zhao, EW Chen, M Mehta, DWH Tung, YL Chua, ...
Nature immunology 21 (2), 186-198, 2020
462020
Facile discovery of surrogate cytokine agonists
M Yen, J Ren, Q Liu, CR Glassman, TP Sheahan, LK Picton, FR Moreira, ...
Cell 185 (8), 1414-1430. e19, 2022
382022
Nonstimulatory peptide–MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling
X Zhao, S Sankaran, J Yap, CT Too, ZZ Ho, G Dolton, M Legut, EC Ren, ...
Nature Communications 9 (1), 2716, 2018
192018
Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy
X Yang, D Nishimiya, S Löchte, KM Jude, M Borowska, CS Savvides, ...
Nature Biotechnology 41 (7), 932-943, 2023
172023
A bead-based method for high-throughput mapping of the sequence-and force-dependence of T cell activation
Y Feng, X Zhao, AK White, KC Garcia, PM Fordyce
Nature Methods 19 (10), 1295-1305, 2022
162022
Shortwave-infrared-light-emitting probes for the in vivo tracking of cancer vaccines and the elicited immune responses
F Ren, F Wang, A Baghdasaryan, Y Li, H Liu, RS Hsu, C Wang, J Li, ...
Nature Biomedical Engineering, 1-14, 2023
92023
Use of single chain MHC technology to investigate co-agonism in human CD8+ T cell activation
X Zhao, M Hamidinia, JAL Choo, CT Too, ZZ Ho, EC Ren, A Bertoletti, ...
Journal of Visualized Experiments, 2019
62019
TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathways
W Chan, YM Cao, X Zhao, EC Schrom, D Jia, J Song, LV Sibener, S Dong, ...
Journal of Experimental Medicine 220 (12), e20231242, 2023
52023
Time required for commitment to T cell proliferation depends on TCR affinity and cytokine response
L Wu, R Balyan, J Brzostek, X Zhao, NRJ Gascoigne
EMBO reports 24 (1), e54969, 2023
42023
The recent advancement of TCR-T cell therapies for cancer treatment: TCR-T cell therapies for cancer treatment
X Zhao, S Shao, L Hu
Acta Biochimica et Biophysica Sinica 56 (5), 663, 2024
12024
Non-stimulatory pMHC enhance CD8 T cell effector functions by recruiting coreceptor-bound Lck
X Zhao, ENY Ng, KWS Leow, Q Wei, N Gascoigne, J Brzostek
Frontiers in Immunology, 4138, 2021
12021
系统目前无法执行此操作,请稍后再试。
文章 1–15